Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Aptevo Therapeutics Inc. (APVO)

NASDAQ

$1.75

$-0.02

(-1.35%)

Pre-Market

Aptevo Therapeutics Inc. (APVO) Live Price Chart

Last updated: ⁦2026-09-16 09:46:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Aptevo Therapeutics Inc. (APVO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.75, with a market capitalisation of $3.26M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.37 to $48.78. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$3.26M
Open	$1.78
Day's High	$52,102,512.00
Day's Low	$1.37
Previous Close	$1.71
Volume	187.00
Average Volume	104.88K
P/E Ratio	--
52-Week High	$48.78
52-Week Low	$1.37
Dividend Yield	--
Earnings Date	--

Aptevo Therapeutics Inc. (APVO) Pre-Market Stock Price

Aptevo Therapeutics Inc. (APVO) is trading at $1.75 in pre-market trading as of 2026-09-16 09:39:00, up 2.46% ($0.04) from the previous close of $1.71

Pre-market trading shows how investors are pricing APVO before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Aptevo Therapeutics Inc. (APVO) 7-Day Stock Price Change

Over the past seven days, Aptevo Therapeutics Inc. (APVO) moved from $1.74 to $1.75, representing a gain of 0.69% ($0.01).

The stock traded between $1.64 and $1.99 during the period. The latest price is near the lower end of the 7-day range, indicating moderate upward.

The average daily volume was 97.52 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

APVO 52-Week Price Position

Position in Range: 0.8%

52W Low$1.37

52W High$48.78

APVO is currently trading at $1.75, placing it 0.8% of the way from its 52-week low of $1.37 to its 52-week high of $48.78. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Aptevo Therapeutics Inc. (APVO)?

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, CD3xCD123, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Aptevo Therapeutics Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	33
Exchange	NASDAQ
Company Website	https://www.aptevotherapeutics.com

How to Buy Aptevo Therapeutics Inc. (APVO) Stock on MEXC

Eligible investors can buy real shares of Aptevo Therapeutics Inc. (APVO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for APVO and Place Your Order

Open the RealStocks trading page and search for APVO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Aptevo Therapeutics Inc. (APVO) stock price today?

Aptevo Therapeutics Inc. (APVO) is currently trading at $ 1.75, up 2.46% ($0.04) from the previous close of $ 1.71. Intraday prices update in real time during regular trading hours.

2.Is APVO stock going up or down today?

As of 2026-09-16 09:39:00, APVO is trading at $ 1.75, up 2.46% ($0.04) from its previous close of $ 1.71. The stock has traded between $ 1.37 and $ 52,102,512.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is APVO pre-market price?

As of 2026-09-16 09:39:00, APVO is trading at $ 1.75 in pre-market trading, up 2.46% ($0.04) from the previous close of $ 1.71. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is APVO after-hours price?

As of 2026-09-16 09:39:00, APVO is trading at $ 1.78 in after-hours trading, up 4.09% ($0.07) from the regular-session close of $ 1.71. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is APVO stock trading now?

APVO trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does APVO sit relative to its 52-week high and low?

Over the past 52 weeks, APVO has traded between a low of $ 1.37 and a high of $ 48.78. At $ 1.75, the stock is positioned 0.8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Aptevo Therapeutics Inc. in?

Aptevo Therapeutics Inc. (APVO) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Aptevo Therapeutics Inc.'s market capitalisation and where is it listed?

Aptevo Therapeutics Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 3.26M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is APVO valued in terms of P/E ratio and EPS?

APVO trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -15.46. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Aptevo Therapeutics Inc. pay a dividend?

Aptevo Therapeutics Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.